Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London
· Delayed Price · Currency is GBP · Price in USD 700.68
+4.42 (0.63%)
At close: Feb 21, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 59.29 billion as of February 21, 2025. Its market cap has decreased by -25.95% in one year.
Market Cap
59.29B
Enterprise Value
47.45B
Revenue
11.34B
Ranking
n/a
PE Ratio
16.82
Stock Price
700.68
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 96.12M to 59.29B, an increase of 61,585.34%. That is a compound annual growth rate of 21.77%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 181.54B |
| GSK plc | 58.32B |
| Haleon | 35.36B |
| Smith & Nephew | 9.01B |
| Hikma Pharmaceuticals | 5.12B |
| ConvaTec Group | 5.06B |
| HUTCHMED (China) | 2.19B |
| Genus | 1.17B |